News

  • ARLG joins forces with COMBACTE on a number of initiatives designed to fight drug-resistant infections

    The U.S.-based Antibacterial Resistance Leadership Group (ARLG), part of the Duke Clinical Research Institute (DCRI) and the University Medical Center (UMC) Utrecht, the managing entity of the COMBACTE (Combatting Bacterial Resistance in Europe) consortium, will work together to solidify a comprehensive global community to combat the threat of antibiotic resistance around the world. “We at the ARLG have long admired the work being done by COMBACTE to increase the efficacy of antimicrobial drug development,” said Vance Fowler, MD, an investigator at the DCRI and co-principal investigator of the ARLG. “Combining our efforts will allow us to maximize the work we both do to stop the advancement of antibacterial resistance.” Read more
  • ARLG at ECCMID

    Support your ARLG colleagues who will be presenting at the 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Amsterdam, Netherlands from April 13-16, 2019. Read more
  • Michael Woodworth, MD, MSc, receives the Southern Society for Clinical Investigation Research Scholar Award

    Congratulations to Michael Woodworth, MD, MSc, for being selected as a recipient of the Southern Society for Clinical Investigation (SSCI) Research Scholar Award. This award provides funding for physician-scientists with innovative research projects related to internal medicine and its subspecialties. Dr. Woodworth will use the award to provide additional project funding for the ARLG ongoing ... Read more
  • Two ARLG PI-Initiated, Laboratory-Based Trials Reached Database Lock

    ARLG Principal Investigators Ritu Banerjee, MD, PhD of Vanderbilt University and Audrey Schuetz, MD, MPH, D (ABMM) of Mayo Clinic have successfully led the RAPIDS-GN and DISK trials, respectively, to completion. The primary objective of RAPIDS-GN is to evaluate the impact of rapid identification and antimicrobial susceptibility testing (AST) on the time to first antibiotic modification ... Read more

ARLG_COMBACTE

Antibiotic Resistance in the News:

Diagnostic developers target antibiotic resistance : Nature News & Comment

Diagnostic developers target antibiotic resistance, Nature.com, October 9, 2015

NIH Funds Nine Antimicrobial Resistance Diagnostics Projects, NIAID, April 9, 2015

Obama battles 'superbugs' with national plan, CNN.com, March 27, 2015

Combating Antibiotic Resistance, FDA, October 14, 2014

National Strategy to Combat Antibiotic-Resistant Bacteria, CDC, September 22, 2014

New Executive Actions to Combat Antibiotic Resistance and Protect Public Health, Whitehouse.gov, September 18, 2014

Executive Order -- Combating Antibiotic-Resistant Bacteria, whitehouse.gov, September 18, 2014

PCAST Releases New Report on Combating Antibiotic Resistance, whitehouse.gov, September 18, 2014

Antimicrobial resistance, WHO, April 2014